Spectrum of low density lipoprotein receptor mutations in Czech hypercholesterolemic patients

被引:4
|
作者
Kuhrová, V [1 ]
Francová, H [1 ]
Zapletalová, P [1 ]
Freiberger, T [1 ]
Fajkusová, L [1 ]
Hrabincová, E [1 ]
Slovácková, R [1 ]
Kozák, L [1 ]
机构
[1] Res Inst Child Hlth, Dept Biochem & Mol Genet, CZ-66262 Brno, Czech Republic
关键词
familial hypercholesterolemia; FH; LDL receptor; LDLR; Czechoslovakian;
D O I
10.1002/humu.1185
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in Czech hypercholesterolemic individuals. A combination of heteroduplex analysis, SSCP, DGGE, DNA sequencing and PCR/restriction analysis was used for this purpose. Molecular searching in the promoter region and coding sequence of the low density lipoprotein receptor (LDLR) gene in 130 patients from 68 unrelated families resulted in the identification of 37 sequence variations. Thirty of them are most likely disease causing mutations. Nineteen mutations were novel (two nonsense, five missense, six nucleotide(s) insertions and six nucleotide(s) deletions). Their pathological effect can be predicted on the basis of their position with respect to previously reported mutations with an estimated reduction of the receptor activity and/or premature termination of translation. These results expand our knowledge of mutations responsible for FH. Seven nucleotide variations were characterized as silent polymorphisms . (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:253 / 253
页数:1
相关论文
共 50 条
  • [21] Low density lipoprotein receptor gene mutations in patients with clinical diagnosis of familial hypercholesterolemia
    Meshkov, AN
    Stambolsky, DV
    Krapivner, SR
    Bochkov, VN
    Kukharchuk, VV
    Malyshev, PP
    KARDIOLOGIYA, 2004, 44 (09) : 58 - 61
  • [22] Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report
    Paththinige, C. S.
    Rajapakse, J. R. D. K.
    Constantine, G. R.
    Sem, K. P.
    Singaraja, R. R.
    Jayasekara, R. W.
    Dissanayake, V. H. W.
    LIPIDS IN HEALTH AND DISEASE, 2018, 17
  • [23] Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia – a preliminary report
    C. S. Paththinige
    J. R. D. K. Rajapakse
    G. R. Constantine
    K. P. Sem
    R. R. Singaraja
    R. W. Jayasekara
    V. H. W. Dissanayake
    Lipids in Health and Disease, 17
  • [24] Sequential analysis of the low density lipoprotein receptor and apolipoprotein B genes of hypercholesterolemic patients from Central Europe
    Plewa, R
    Luczak, M
    Bolewski, A
    Wierzchowiecki, J
    Siminiak, T
    EUROPEAN HEART JOURNAL, 2002, 23 : 416 - 416
  • [25] Aortic valve calcium score in hypercholesterolemic patients with and without low-density lipoprotein receptor gene mutation
    Galaska, Rafal
    Kulawiak-Galaska, Dorota
    Chmara, Magdalena
    Chlebus, Krzysztof
    Studniarek, Michal
    Fijalkowski, Marcin
    Wasag, Bartosz
    Rynkiewicz, Andrzej
    Gruchala, Marcin
    PLOS ONE, 2018, 13 (12):
  • [26] Therapeutic effects of rosuvastatin in hypercholesterolemic prediabetic mice in the absence of low density lipoprotein receptor
    Gurzeler, Erika
    Aavik, Einari
    Laine, Anssi
    Valkama, Teemu
    Niskanen, Henri
    Huusko, Jenni
    Kaikkonen, Minna U.
    Yla-Herttuala, Seppo
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2019, 1863 (02): : 481 - 490
  • [27] Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients
    Martínez-Castelao, A
    Grinyó, JM
    Fiol, C
    Castiñeiras, MJ
    Hurtado, I
    Gil-Vernet, S
    Serón, D
    Porta, I
    Miñarro, A
    Villarroya, A
    Alsina, J
    KIDNEY INTERNATIONAL, 1999, 56 : S231 - S234
  • [28] The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients
    Thallinger, C
    Urbauer, E
    Lackner, E
    Graselli, U
    Kostner, K
    Wolzt, M
    Joukhadar, C
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (12) : 551 - 557
  • [29] Functional Analysis of Low Density Lipoprotein Receptor Variants in Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of Low Density Lipoprotein Receptor Activity
    Banerjee, Poulabi
    Ali, Shazia
    Tarabocchia, Michel
    Bouzelmat, Aurelie
    Dos Santos Alves, Ana Catarina
    Etxebarria, Aitor
    Benito-Vicente, Asior
    Bourbon, Mafalda
    Pordy, Robert
    Gipe, Daniel
    Gaudet, Daniel
    Martin, Cesar
    CIRCULATION, 2017, 136
  • [30] MUTATIONS IN THE LOW-DENSITY LIPOPROTEIN RECEPTOR GENE IN A DUTCH POPULATION OF FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS
    TOP, B
    FRANTS, RR
    LEUVEN, JAG
    HAVEKES, LM
    ARTERIOSCLEROSIS, 1989, 9 (05): : A768 - A768